Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Treprostinil Iontophoresis in Systemic Sclerosis
NCT01554540Phase 2Unknown
- Sponsor
- CHU Grenoble Alpes
- Start
- Feb 2012
- Primary completion
- Oct 2013
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of treprostinil in systemic sclerosis (SSc), sponsored by CHU Grenoble Alpes. Status: unknown.
02
Drugs
treprostinil
03
Conditions
systemic sclerosis (SSc)
Beyond the preview
Go deeper on NCT01554540.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01554540.